| Literature DB >> 28716800 |
Anna Kontos1, Kurt Lushington2, James Martin3,4, Quenten Schwarz5, Ryan Green6, David Wabnitz7, Xiangjun Xu5, Elke M Sokoya8, Scott Willoughby9, Mathias Baumert10, Antonio Ferrante3,11, Melissa La Forgia12, Declan Kennedy3,4.
Abstract
BACKGROUND: Sleep disordered breathing in children is associated with increased blood flow velocity and sympathetic overactivity. Sympathetic overactivity results in peripheral vasoconstriction and reduced systemic vascular compliance, which increases blood flow velocity during systole. Augmented blood flow velocity is recognized to promote vascular remodeling. Importantly, increased vascular sympathetic nerve fiber density and innervation in early life plays a key role in the development of early-onset hypertension in animal models. Examination of sympathetic nerve fiber density of the tonsillar arteries in children undergoing adenotonsillectomy for Sleep disordered breathing will address this question in humans. METHODS ANDEntities:
Keywords: arterial blood flow; arterial stiffness; autonomic function; flow‐mediated dilatation; pediatrics; shear stress; sleep disordered breathing; sympathetic; sympathetic nerve fibre density; vasculature
Mesh:
Year: 2017 PMID: 28716800 PMCID: PMC5586314 DOI: 10.1161/JAHA.117.006137
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Figure 1Sonogram of the brachial artery, 10 cm proximal from the elbow, green box determines the region of interest. Ten equidistant red lines were used to determine the frame by frame diameter difference over 180 seconds (15 seconds precuff release until 165 seconds).
Figure 2Example of the mean dilatation response from a child with sleep disordered breathing. The computer program generates a graph showing the raw data in blue and the averaged data in green.
Figure 3Representative images showing 2 dorsal lingual arteries from 2 children with sleep disordered breathing (left panel VTi=9 and SNFD=1803 and right panel VTi=16 and SNFD=2120). Red immunofluorescence indicates smooth muscle actin (SMA), and green immunofluorescence represents tyrosine hydroxylase (TH) an enzyme found in sympathetic nerve fibers. SNFD indicates sympathetic nerve fiber density; VTi, velocity time integral.
Figure 4Immunofluorescence for tyrosine hydroxylase on the dorsal lingual artery; white circles indicate the 3 regions of interest selected by the analyst for green pixel/region of interest, sympathetic nerve fiber density score.
Figure 5Blood flow velocity Doppler image (top panel), and the corresponding dorsal lingual arteries sympathetic nerve fiber images (bottom panel) for 3 representative participants. SNFD indicates Sympathetic Nerve Fiber Density; VTI, velocity time integral.
Mean (SD) Anthropometric, FMD, Pupillary Light Reflex, Platelet Aggregation, and SNFD Values Together With SNFD Pearson‐r Correlation Values (N=13)
| Variable | Mean (SD) | SNFD Correlation Values |
|---|---|---|
| Anthropometric | ||
| Age, y | 11.1 (4.1) | 0.24 |
| Height, cm | 148.2 (22.5) | 0.25 |
| Weight, kg | 54.4 (30.7) | 0.22 |
| BMI kg/m̂2 | 22.6 (6.8) | 0.24 |
| BMI (%ile) | 76.7 (31.6) | 0.11 |
| Flow‐mediated dilatation | ||
| Resting brachial artery diameter, cm | 0.29 (0.06) | 0.22 |
| Resting peak systolic velocity, mm/s | 113.4 (34.1) | 0.64 |
| Resting velocity time integral, mm2 | 20.4 (12.9) | 0.63 |
| FMD60s, % | 5.50 (5.90) | −0.04 |
| FMDMax, % | 9.22 (5.90) | −0.09 |
| FMDTime‐to‐Maximum, s | 68.4 (30.6) | 0.41 |
| Heart rate, bpm | 72.1 (8.71) | −0.39 |
| Pupillary light reflex | ||
| NPI | 4.26 (0.22) | −0.71 |
| Baseline pupillary diameter, mm | 6.98 (0.41) | 0.33 |
| Constricted diameter, mm | 4.41 (0.43) | 0.58 |
| Change from baseline diameter, % | 0.37 (0.04) | −0.70 |
| Constriction latency, s | 0.24 (0.37) | −0.65 |
| Mean constriction velocity, mm/s | 3.41 (0.44) | −0.64 |
| Peak constriction velocity, mm/s | 5.43 (0.63) | −0.63 |
| Postconstriction dilation velocity, mm/s | 1.48 (0.13) | −0.59 |
| Platelet aggregation | ||
| CollagenAUC | 42.9 (11.0) | 0.43 |
| CollagenAggregation | 97.1 (16.8) | 0.47 |
| CollagenVelocity | 14.3 (3.4) | 0.67 |
| lADPAUC | 19.2 (11.1) | 0.50 |
| lADPAggregation | 35.8 (18.3) | 0.52 |
| lADPVelocity | 5.23 (1.92) | 0.36 |
| TRAPAUC | 72.3 (14.9) | 0.34 |
| TRAPAggregation | 109.7 (21.1) | 0.27 |
| TRAPVelocity | 19.8 (4.8) | 0.50 |
| ASPAUC | 46.4 (17.4) | 0.46 |
| ASPAggregation | 74.9 (24.9) | 0.34 |
| ASPVelocity | 13.4 (5.2) | 0.57 |
| ADPAUC | 43.4 (12.0) | 0.52 |
| ADPAggregation | 71.8 (18.4) | 0.43 |
| ADPVelocity | 11.7 (3.17) | 0.65 |
| SNFD (pixel per region of interest) | 2278 (370) | |
ADP indicates adenosine diphosphate; ASP, aspirin dialuminate; AUC, area under the curve; BMI, body mass index; FMD, flow‐mediated dilatation; lADP, low‐dose adenosine diphosphate; NPI, Neuronal Pupillary Index; SNFD, sympathetic nerve fiber density; TRAP, thrombin receptor activating peptide.
P<0.05.
P<0.01.
Mean (SD) PSG Values and Correlation With SNFD (N=13)
| PSG Variable | Mean (SD) | Pearson‐ |
|---|---|---|
| Total sleep time, min | 418.8 (55.7) | −0.19 |
| NREM 1 (%TST) | 12.6 (7.7) | 0.19 |
| NREM 2 (%TST) | 38.7 (10.4) | −0.03 |
| SWS (%TST) | 33.1 (13.2) | −0.36 |
| REM (%TST) | 15.6 (4.6) | 0.05 |
| Arousals/h sleep time | 21.2 (18.3) | 0.05 |
| Spontaneous arousals/h sleep time | 10.6 (4.5) | 0.22 |
| Respiratory arousal/h sleep time | 10.3 (18.8) | −0.02 |
| Central apnea hypopnea index | 0.45 (0.43) | −0.03 |
| Obstructive apnea hypopnea index | 11.8 (24.0) | −0.08 |
| Average SpO2desat (%TST) | 96.2 (1.2) | −0.17 |
| Average SpO2desat (%REM) | 96.7 (0.9) | −0.05 |
| Average SpO2desat (%NREM) | 96.2 (1.1) | −0.13 |
| Nadir SpO2, % | 89.7 (4.3) | −0.07 |
| REM Nadir SpO2, % | 92.4 (2.5) | −0.25 |
| NREM Nadir SpO2, % | 90.7 (4.7) | −0.07 |
Spearman‐rho correlation values. NREM indicates non‐rapid‐eye movement; PSG, polysomnography; REM, rapid‐eye movement; SNFD, sympathetic nerve fiber density; SpO2, arterial oxygen saturation; SWS, slow wave sleep; TST, total sleep time.
Correlations Results Between Pupillary Light Reflex and FMD Variables
| Pupillometry (N=12) | FMD | |||||
|---|---|---|---|---|---|---|
| Resting Brachial Artery Diameter | Resting Velocity Time Integral | Resting Peak Systolic Velocity | FMD60s | FMDMax | FMDTime‐to‐Maximum | |
| NPI | −0.27 | −0.40 | −0.31 | 0.15 | 0.12 | −0.13 |
| Baseline pupillary diameter | −0.76 | 0.37 | 0.50 | −0.39 | −0.47 | 0.21 |
| Constricted diameter | −0.59 | 0.48 | 0.59 | −0.43 | −0.50 | 0.24 |
| Percent change from baseline diameter | 0.26 | −0.62 | −0.55 | 0.36 | 0.38 | −0.23 |
| Constriction latency | −0.07 | 0.19 | −0.17 | −0.23 | −0.22 | 0.04 |
| Mean constriction velocity | 0.19 | −0.77 | −0.51 | 0.32 | 0.24 | 0.11 |
| Peak constriction velocity | 0.25 | −0.67 | −0.71 | 0.28 | 0.14 | −0.40 |
| Postconstriction dilation velocity | −0.01 | −0.80 | −0.78 | −0.23 | −0.33 | −0.66 |
FMD indicates flow‐mediated dilatation; NPI, Neuronal Pupillary Index.
P<0.05.
P<0.01.
Correlations Results Between Platelet Aggregation, Pupillary Light Reflex, and FMD Variables
| Platelet Aggregation | Pupillometry (N=12) | FMD (N=13) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NPI | Baseline Pupillary Diameter | Constricted Diameter | Percent Change From Baseline Diameter | Constriction Latency | Mean Constriction Velocity | Peak Constriction cVelocity | Postconstriction Dilation Velocity | Resting Brachial Artery Diameter | Resting Velocity Time Integral | Resting Peak Systolic Velocity | FMD60s | FMDMax | FMDTime‐to‐Maximum | |
| CollagenAggregation | −0.60 | −0.17 | 0.13 | −0.41 | 0.65 | −0.60 | −0.77 | −0.38 | 0.30 | 0.64 | 0.43 | −0.03 | 0.18 | 0.47 |
| lADPAggregation | −0.57 | −0.00 | 0.20 | −0.37 | 0.63 | −0.39 | −0.52 | −0.34 | 0.17 | 0.36 | 0.35 | 0.14 | 0.19 | 0.25 |
| TRAPAggregation | −0.47 | −0.42 | −0.14 | −0.17 | 0.50 | −0.35 | −0.47 | 0.11 | 0.37 | 0.35 | 0.17 | −0.32 | 0.1 | 0.22 |
| ASPAggregation | −0.67 | 0.18 | 0.43 | −0.60 | 0.69 | −0.61 | −0.75 | −0.60 | 0.20 | 0.23 | 0.09 | −0.12 | −0.10 | 0.23 |
| ADPAggregation | −0.65 | −0.31 | −0.14 | −0.28 | 0.79 | −0.54 | −0.65 | −0.13 | 0.21 | 0.35 | 0.27 | −0.14 | 0.05 | 0.31 |
ADP indicates adenosine diphosphate; ASP, aspirin dialuminate; FMD, flow‐mediated dilatation; lADP, low‐dose adenosine diphosphate; NPI, Neuronal Pupillary Index; TRAP, thrombin receptor activating peptide.
P<0.05.
P<0.01.